**Core Concept**
The HER-2/neu gene, also known as ERBB2, is a proto-oncogene that encodes a receptor tyrosine kinase involved in cell proliferation and survival. Overexpression or amplification of the HER-2/neu gene leads to uncontrolled cell growth and contributes to breast carcinogenesis.

**Why the Correct Answer is Right**
The HER-2/neu gene overexpression is associated with increased activation of downstream signaling pathways, including the PI3K/AKT and MAPK/ERK pathways. This results in enhanced cell proliferation, survival, and angiogenesis, ultimately promoting tumor growth and metastasis. The HER-2/neu protein is also involved in the regulation of cell adhesion and migration.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because HER-2/neu overexpression is not directly related to the development of breast carcinoma through the activation of estrogen receptors.
**Option B:** This option is incorrect because the HER-2/neu gene is not primarily involved in the regulation of apoptosis in breast carcinoma.
**Option C:** This option is incorrect because the HER-2/neu gene is not directly associated with the development of breast carcinoma through the activation of the p53 tumor suppressor protein.

**Clinical Pearl / High-Yield Fact**
The HER-2/neu gene is amplified in approximately 20% of breast carcinomas, and its overexpression is associated with a poorer prognosis. Trastuzumab, a monoclonal antibody targeting the HER-2/neu protein, is a standard treatment for HER-2/neu-positive breast cancer.

**Correct Answer: D. Overactivation of downstream signaling pathways.**